723
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Adipokines are possible risk markers for aortic stenosis requiring surgery

, , , , , ORCID Icon & show all
Article: 2247193 | Received 06 Feb 2023, Accepted 08 Aug 2023, Published online: 17 Aug 2023

References

  • Thaden JJ, Nkomo VT, Enriquez-Sarano M. The global burden of aortic stenosis. Prog Cardiovasc Dis. 2014; 56(6):565–571. doi: 10.1016/j.pcad.2014.02.006.
  • Lindman BR, Clavel MA, Mathieu P, et al. Calcific aortic stenosis. Nat Rev Dis Primers. 2016;2:16006. doi: 10.1038/nrdp.2016.6.
  • Joseph J, Naqvi SY, Giri J, et al. Aortic stenosis: pathophysiology, diagnosis, and therapy. Am J Med. 2017;130(3):253–263. Mardoi: 10.1016/j.amjmed.2016.10.005.
  • Otto CM, Kuusisto J, Reichenbach DD, et al. Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation. 1994;90(2):844–853. doi: 10.1161/01.cir.90.2.844.
  • Yan AT, Koh M, Chan KK, et al. Association Between cardiovascular risk factors and aortic stenosis: the CANHEART aortic stenosis study. J Am Coll Cardiol. 2017;69(12):1523–1532. doi: 10.1016/j.jacc.2017.01.025.
  • Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular health study. J Am Coll Cardiol. 1997;29(3):630–634. doi: 10.1016/s0735-1097(96)00563-3.
  • Meidell Blylod V, Rinnström D, Pennlert J, et al. Traditional cardiovascular risk factors and their relation to future surgery for valvular heart disease or ascending aortic disease: a case-referent study. J Am Heart Assoc. 2022;11(14)[:e023954. Mismatch]
  • Redfors B, Furer A, Lindman BR, et al. Biomarkers in aortic stenosis: a systematic review. Structural Heart. 2017;1(1-2):18–30. doi: 10.1080/24748706.2017.1329959.
  • Ljungberg J, Holmgren A, Bergdahl IA, et al. Lipoprotein(a) and the apolipoprotein B/A1 ratio independently associate With surgery for aortic stenosis only in patients with concomitant coronary artery disease. J Am Heart Assoc. 2017;6(12):1–11. doi: 10.1161/JAHA.117.007160.
  • Holmgren A, Ljungberg J, Hultdin J, et al. Troponin T but not C reactive protein is associated with future surgery for aortic stenosis: a population-based nested case-referent study. Open Heart. 2020;7(2):1–10. doi: 10.1136/openhrt-2020-001325.
  • Soderberg S, Ahren B, Jansson JH, et al. Leptin is associated with increased risk of myocardial infarction. J Intern Med. 1999;246(4):409–418. doi: 10.1046/j.1365-2796.1999.00571.x.
  • Soderberg S, Stegmayr B, Stenlund H, et al. Leptin, but not adiponectin, predicts stroke in males. J Intern Med. 2004;256(2):128–136. doi: 10.1111/j.1365-2796.2004.01351.x.
  • Martin SS, Qasim A, Reilly MP. Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease. J Am Coll Cardiol. 2008;52(15):1201–1210. doi: 10.1016/j.jacc.2008.05.060.
  • Bełtowski J. Role of leptin in blood pressure regulation and arterial hypertension. J Hypertens. 2006; 24(5):789–801. doi: 10.1097/01.hjh.0000222743.06584.66.
  • Lilja M, Rolandsson O, Norberg M, et al. The impact of leptin and adiponectin on incident type 2 diabetes is modified by sex and insulin resistance [research support, Non-U.S. Metab Syndr Relat Disord. 2012;10(2):143–151. doi: 10.1089/met.2011.0123.
  • Li S, Shin HJ, Ding EL, et al. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. Jama. 2009;302(2):179–188. doi: 10.1001/jama.2009.976.
  • Glader CA, Birgander LS, Soderberg S, et al. Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis. Eur Heart J. 2003;24(2):198–208. doi: 10.1016/s0195-668x(02)00385-8.
  • Rosa M, Paris C, Sottejeau Y, et al. Leptin induces osteoblast differentiation of human valvular interstitial cells via the akt and ERK pathways. Acta Diabetol. 2017;54(6):551–560. doi: 10.1007/s00592-017-0980-3.
  • Mohty D, Pibarot P, Cote N, et al. Hypoadiponectinemia is associated with valvular inflammation and faster disease progression in patients with aortic stenosis. Cardiology. 2011;118(2):140–146. doi: 10.1159/000327588.
  • Norberg M, Wall S, Boman K, et al. The västerbotten intervention programme: background, design and implications. Glob Health Action. 2010;3:1–15.
  • Eriksson M, Holmgren L, Janlert U, et al. Large improvements in major cardiovascular risk factors in the population of northern Sweden: the MONICA study 1986–2009. J Intern Med. 2011;269(2):219–231. doi: 10.1111/j.1365-2796.2010.02312.x.
  • Hallmans G, Agren A, Johansson G, et al. Cardiovascular disease and diabetes in the Northern Sweden health and disease study cohort – evaluation of risk factors and their interactions [evaluation studies]. Scand J Public Health Suppl. 2003;61:18–24. doi: 10.1080/14034950310001432.
  • Ljungberg J, Janiec M, Bergdahl IA, et al. Proteomic biomarkers for incident aortic stenosis requiring valvular replacement. Circulation. 2018;138(6):590–599. doi: 10.1161/CIRCULATIONAHA.117.030414.
  • Ljungberg J, Johansson B, Engstrom KG, et al. Traditional cardiovascular risk factors and their relation to future surgery for valvular heart disease or ascending aortic disease: a Case-Referent study. J Am Heart Assoc. 2017;6(5):1–12.
  • Ljungberg J, Johansson B, Bergdahl IA, et al. Mild impairment of renal function (shrunken pore syndrome) is associated with increased risk for future surgery for aortic stenosis. Scand J Clin Lab Invest. 2019;79(7):524–530. doi: 10.1080/00365513.2019.1664761.
  • Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Report of a WHO/IDF Consultation World Health Organization, 2006.
  • Flower L, Ahuja RH, Humphries SE, et al. Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin. Cytokine. 2000;12(11):1712–1716. doi: 10.1006/cyto.2000.0764.
  • Lee SA, Kallianpur A, Xiang YB, et al. Intra-individual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies. Cancer Epidemiol Biomarkers Prev. 2007;16(11):2464–2470. doi: 10.1158/1055-9965.EPI-07-0374.
  • Lilja M, Rolandsson O, Shaw JE, et al. Higher leptin levels in Asian Indians than Creoles and Europids: a potential explanation for increased metabolic risk [research support, Non-U.S. Int J Obes. 2010;34(5):878–885. doi: 10.1038/ijo.2010.19.
  • Ciccone M, Vettor R, Pannacciulli N, et al. Plasma leptin is independently associated with the intima-media thickness of the common carotid artery. Int J Obes Relat Metab Disord. 2001;25(6):805–810. doi: 10.1038/sj.ijo.0801623.
  • Maahs DM, Ogden LG, Kinney GL, et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation. 2005;111(6):747–753. 5doi: 10.1161/01.CIR.0000155251.03724.A5.
  • Soderberg S, Olsson T, Eliasson M, et al. Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women. J Intern Med. 1999;245(5):533–543. doi: 10.1046/j.1365-2796.1999.00472.x.
  • Nakata M, Yada T, Soejima N, et al. Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes. 1999;48(2):426–429. doi: 10.2337/diabetes.48.2.426.
  • Shin MK, Eraso CC, Mu YP, et al. Leptin induces hypertension acting on transient receptor potential melastatin 7 channel in the carotid body. Circ Res. 2019;125(11):989–1002. doi: 10.1161/CIRCRESAHA.119.315338.
  • Schneiderman J, Schaefer K, Kolodgie FD, et al. Leptin locally synthesized in carotid atherosclerotic plaques could be associated with lesion instability and cerebral emboli. J Am Heart Assoc. 2012;1(5):e001727.
  • Sasako T, Kadowaki H, Fujiwara T, et al. Severe aortic stenosis during leptin replacement therapy in a patient with generalized lipodystrophy-associated progeroid syndrome due to an LMNA variant: a case report. J Diabetes Investig. 2022;13(9):1636–1638. doi: 10.1111/jdi.13827.
  • Arita Y, Kihara S, Ouchi N, et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation. 2002;105(24):2893–2898. doi: 10.1161/01.cir.0000018622.84402.ff.
  • Marsche G, Zelzer S, Meinitzer A, et al. Adiponectin predicts high-density lipoprotein cholesterol efflux capacity in adults irrespective of body mass index and fat distribution. J Clin Endocrinol Metab. 2017;102(11):4117–4123. doi: 10.1210/jc.2017-00933.
  • Gucuk Ipek E, Guray U, Guray Y, et al. Relationship between serum adiponectin levels and calcific aortic valve disease. Kardiol Pol. 2013;71(3):241–246. doi: 10.5603/KP.2013.0035.
  • Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation. 2005;111(7):920–925. doi: 10.1161/01.CIR.0000155623.48408.C5.
  • Iacobellis G. Epicardial adipose tissue in contemporary cardiology. Nat Rev Cardiol. 2022;19(9):593–606. doi: 10.1038/s41569-022-00679-9.
  • Christou GA, Andriopoulou CE, Liakopoulou A, et al. Unraveling the role of resistin, retinol-binding protein 4 and adiponectin produced by epicardial adipose tissue in cardiac structure and function: evidence of a paracrine effect. Hormones. 2023;22(2):321–330. doi: 10.1007/s42000-023-00447-5.
  • Katsiki N, Mantzoros C, Mikhailidis DP. Adiponectin, lipids and atherosclerosis. Curr Opin Lipidol. 2017; 28(4):347–354. doi: 10.1097/MOL.0000000000000431.
  • Zhang T, Yang P, Li T, et al. Leptin expression in human epicardial adipose tissue is associated with local coronary atherosclerosis. Med Sci Monit. 2019;25:9913–9922. doi: 10.12659/MSM.918390.
  • Mahabadi AA, Kahlert HA, Dykun I, et al. Epicardial adipose tissue thickness independently predicts severe aortic valve stenosis. J Heart Valve Dis. 2017;26(3):262–267.